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Background. Wolff, Parkinson and White (I) in 1930 reported
an electrophysiologic syndrome based on their observation
of 11 "healthy young" people who had "bundle branch
block with short PR interval" and who were "prone to
paroxysmal tachycardia." However, substantial progress in
understanding the pathophysiology and in devising therapy
for the various complex arrhythmias in patients with this
syndrome had to wait for the development of clinical elec-
trophysiologic testing, antiarrhythmic drugs and open heart
surgery. Electrophysiologic tests have their origin in the
recording of the bundle of His electrogram, first documented
in the dog by Alanis et al. (2) in 1958. The first successful
termination of atrioventricular (AV) reentrant tachycardia
(circus movement, AV tachycardia) in a patient with Wolff-
Parkinson-White syndrome was accomplished in 1968 by
Ryan et al. (3) by asynchronous ventricular capture by an
implanted permanent ventricular pacemaker. Most of our
current approaches employed for patients with this syn-
drome are based on the remarkable progress made in the
1970s, as summarized in the now classic review article by
Gallagher et al. (4).
This syndrome is relatively common (occurring in about 1
in every 1,000 people) and its clinical manifestations vary
greatly, ranging from a totally asymptomatic benign course
in some patients to a malignant course in others who die of
ventricular fibrillation as a result of an extremely rapid
ventricular response in the presence of atrial fibrillation. The
rapid ventricular response during atrial fibrillation results
from rapid conduction over the accessory pathway and is
related to its extremely short anterograde refractory period
(5). Because routine use of clinical electrophysiologic tests
in all patients with this syndrome is prohibitively costly,
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electrocardiographic (ECG) clues associated with a benign
clinical course might obviate such tests and would thus be of
great value. Several such clues have been proposed by
Wellens (6). These include an intermittent pre-excitation
pattern, loss of a pre-excitation pattern with exercise, ab-
sence of extremely short RR intervals during atrial fibrilla-
tion and loss of a pre-excitation pattern after administration
of ajmaline or procainamide. The first three clues have been
shown to be predictors of a relatively prolonged anterograde
refractory period of the accessory pathway (5,7,8). How-
ever, the predictive value of intravenous procainamide, as
suggested in a small initial study (9), was not substantiated
by a larger subsequent study (10).
Patients with multiple accessory pathways. The presence
of multiple accessory pathways can be diagnosed by elec-
trophysiologic testing and by intraoperative mapping (4,11);
in one series they were identified in 52 (1.3%) of 3,880
patients with a pre-excitation syndrome (II). Physicians who
care for patients with this syndrome must be aware of the
possible presence of multiple accessory pathways for several
reasons: I) Failure to recognize them may result in failure of
surgical therapy. 2) There is some evidence to suggest that
patients with such pathways may be more likely than pa-
tients with a single accessory pathway to develop ventricular
fibrillation. 3) Complex cardiac arrhythmias in these patients
may be diagnosed incorrectly unless these pathways have
been recognized. Thus, the development of ECG clues that
accurately predict the presence of multiple accessory path-
ways would enhance the management of such patients.
In the September issue of the Journal, Wellens and his
associates (12) presented six ECG clues as predictors for the
presence of multiple accessory pathways, Of 314 patients
with a pre-excitation syndrome undergoing electrophysio-
logic testing, 17 patients were diagnosed as having multiple
accessory pathways. The presence of these pathways was
validated by intraoperative mapping in 8 of the 17. Twelve
lead ECGs from these 17 patients were retrospectively
analyzed. In 12 of the 17 patients, one or more of the
following six ECG clues to the presence of multiple acces-
sory pathways were observed: 1) two or more different P
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Figure 1. An alternative theoretic mechanism for two different P
wave configurations during orthodromic circus movement tachycar-
dia. Atrial activation in this simplified scheme is represented by two
activation pathways (AP 1 and 2), producing one type of P wave
during orthodromic circus movement tachycardia. With the devel-
opment of intraatrial conduction delay at the site marked by an
asterisk along activation pathway I, atrial activation proceeds ex-
clusively along pathway 2, generating a P wave differing in config-
uration from the first P wave. AVN = atrioventricular node; His =
bundle of His.
wave configurations during orthodromic circus movement
tachycardia (four patients); 2) a discrepancy between the
estimated site of the ventricular insertion of an accessory
pathway during antidromic tachycardia and the estimated
site of the atrial insertion of an accessory pathway during
orthodromic circus movement tachycardia (seven patients);
3) atrial fibrillation with two or more pre-excitation patterns
(six patients); 4) a spontaneous and direct switch from
orthodromic to antidromic circus movement tachycardia or
vice versa (two patients); 5) a spontaneous and direct switch
from one type of antidromic tachycardia to another (two
patients); and 6) a change in pre-excitation pattern after the
administration of ajmaline or procainamide (three patients).
Although our current understanding of the electrophysi-
ology of pre-excitation syndromes tends to make multiple
accessory pathways an appealing mechanism responsible for
most of these ECG clues, it is essential to show that these
clues are unique to patients with multiple accessory path-
ways and are either rare or nonexistent in patients with a
single accessory pathway. Before these clues are widely
accepted, it is also important to demonstrate that these
phenomena are directly related to the presence of multiple
accessory pathways and not to other abnormal electrophys-
iologic characteristics of either atrial or ventricular myocar-
dium. For example, two different P wave configurations
during orthodromic circus movement tachycardia could the-
oretically occur because of intermittent intraatrial conduc-
tion block (Fig. I). Similarly, a change in pre-excitation
Figure 2. An alternative theoretic mechanism for a change in
pre-excitation pattern induced by procainamide or ajmaline. Before
administration of procainamide or ajmaline, ventricular activation
originating from the accessory pathway (AP) proceeds along the
dotted line, producing one type of delta wave. Under the effect of
procainamide or ajmaline, intraventricular conduction block takes
place at a site marked by the asterisk, forcing local conduction to
proceed along acircuitous route and thereby giving rise to adifferent
delta wave. SA = sinoatrial node; other abbreviations as in Figure I.
pattern with administration of ajmaline or procainamide
could also be a result of intraventricular conduction block
induced by these drugs (Fig. 2). With respect to the occur-
rence of two or more pre-excitation patterns during atrial
fibrillation, a rapid ventricular response during atrial fibril-
lation often makes it difficult to distinguish between varying
pre-excitation pathway and rate-dependent bundle branch
block.
Clinical implications. The clinical spectrum for patients
with this relatively common congenital cardiac disorder
varies widely from an asymptomatic benign clinical course
to a malignant course ending abruptly with ventricular
fibrillation. Fortunately, various forms of effective therapy
including surgical dissection of accessory pathways are now
available for those patients at high risk of sudden arrhythmic
death. However, electrophysiologic testing is not cost-
effective as a screening test. Furthermore, no firm guidelines
for the utilization of electrophysiologic testing have been
established to date (13). Thus, it is most important that the
theoretically appealing ECG clues to multiple accessory
pathways proposed by Wellens et al. (2) be studied system-
atically and be validated by surgical ablation in future large
scale, perhaps multicenter studies. At the same time we need
to confirm those ECG clues that are believed to be associ-
ated with a benign clinical course. such as intermittent
pre-excitation, loss of pre-excitation pattern with exercise,
absence of extremely short RR intervals during atrial fibril-
lation and loss of pre-excitation with procainamide or ajma-
line.
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